Teton Advisors Inc. Sells 12,900 Shares of Surmodics, Inc. (NASDAQ:SRDX)

Teton Advisors Inc. lowered its holdings in shares of Surmodics, Inc. (NASDAQ:SRDX) by 27.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 33,500 shares of the company’s stock after selling 12,900 shares during the quarter. Teton Advisors Inc.’s holdings in Surmodics were worth $1,218,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Strs Ohio grew its holdings in shares of Surmodics by 97.2% during the 4th quarter. Strs Ohio now owns 7,100 shares of the company’s stock valued at $258,000 after purchasing an additional 3,500 shares during the last quarter. Los Angeles Capital Management LLC grew its holdings in shares of Surmodics by 149.2% during the 3rd quarter. Los Angeles Capital Management LLC now owns 34,916 shares of the company’s stock valued at $1,120,000 after purchasing an additional 20,906 shares during the last quarter. Panagora Asset Management Inc. bought a new position in shares of Surmodics during the 3rd quarter valued at $683,000. Acadian Asset Management LLC grew its holdings in shares of Surmodics by 18.8% during the 3rd quarter. Acadian Asset Management LLC now owns 354,738 shares of the company’s stock valued at $11,377,000 after purchasing an additional 56,012 shares during the last quarter. Finally, Moody National Bank Trust Division grew its holdings in shares of Surmodics by 14.8% during the 4th quarter. Moody National Bank Trust Division now owns 10,341 shares of the company’s stock valued at $376,000 after purchasing an additional 1,331 shares during the last quarter. Institutional investors own 96.63% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Needham & Company LLC reissued a “buy” rating and issued a $47.00 price target on shares of Surmodics in a report on Wednesday, April 10th. StockNews.com lowered shares of Surmodics from a “strong-buy” rating to a “buy” rating in a report on Wednesday, April 24th.

Surmodics Trading Down 0.6 %

Surmodics stock traded down $0.16 during trading hours on Tuesday, reaching $25.69. The stock had a trading volume of 65,825 shares, compared to its average volume of 57,428. The stock has a market cap of $365.83 million, a PE ratio of 67.61 and a beta of 1.01. Surmodics, Inc. has a 52 week low of $16.79 and a 52 week high of $39.41. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.84 and a quick ratio of 3.97. The company has a fifty day simple moving average of $28.66 and a 200-day simple moving average of $31.65.

About Surmodics

Surmodics, Inc, together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD).